During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

Currently, most of the patients undergoing transplants are older patients, so many of them are getting reduced intensity ...

Medexus Pharmaceuticals (TSX:MDP) has revealed that the U.S. Food and Drug Administration has extended the review period for ...

The pre-HSCT treatment includes initial and bridging treatment. The efficacy of DAC monotherapy versus DAC combined with cytotoxic chemotherapy(C-DAC) as initial treatment was compared, followed by ...